Back to search

Switzerland· 65730001

Bexsero, Injektionssuspension

A meningokokkus b, multikomponenten-impfstoff product, registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B. The same ATC class is registered in 11 of our 19 countries.

Cat B (Swissmedic)ATC J07AH09

Checked against the register on

Informational only — not a medical device.

SOURCE REGISTER · CHPublic registernormalisedBexsero, InjektionssuspensionATCJ07AH09REGISTER NO.65730001PACKS LISTED0CHECKEDJune 26, 2026

Where it is registered

Meningokokkus b, multikomponenten-impfstoff is registered in 11 of 19 countries.

Countries holding a registration under ATC J07AH09 (meningokokkus b, multikomponenten-impfstoff), each read from that country’s own register.

  • This record: Switzerland
  • 7 of them publish a price we can compare per daily dose

Meningokokkus b, multikomponenten-impfstoff · ATC J07AH09

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Manufacturer
GlaxoSmithKline AG
Country
Switzerland (CH)
ATC code
J07AH09
ATC class
Meningokokkus B, Multikomponenten-Impfstoff
Swissmedic category
B
Reimbursed
No
Last checked
June 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e1df6ede-1cf0-4fff-b032-282e902f2ba0
GET /v1/drugs/e1df6ede-1cf0-4fff-b032-282e902f2ba0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Impfstoffe"
}

See everything about meningokokkus b, multikomponenten-impfstoff.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.